XML 13 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flow from operating activities    
Net loss $ (76,842) $ (57,611)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Depreciation expense 235 260
Amortization expense 207 193
Share-based compensation expense 8,160 12,326
Net foreign exchange impacts 10,792 9,965
Other income, net (2,600) (3,520)
Income tax expense 11 521
Change in operating assets and liabilities:    
Decrease/(Increase) in trade receivables 994 (293)
Decrease/(increase) in other current assets 7,757 (1,722)
Decrease in R&D benefit receivable 3,851 1,744
Decrease in other long-term assets 3,401 558
(Decrease)/increase in trade and other payables (502) 2,187
Decrease in contract liabilities (302) (4,626)
Decrease in operating lease liabilities (146) (141)
Net cash provided by/(used in) operations (44,984) (40,159)
Cash flow from investing activities    
Redemption of term deposits 98,036 24,856
Purchase of term deposits (92,635) (112,798)
Purchase of property, plant and equipment (55) (149)
Net cash provided by/(used in) investing activities 5,346 (88,091)
Cash flow from financing activities    
Proceeds from issue of ordinary shares 15 142,185
Net cash provided by financing activities 15 142,185
(Decrease)/increase in cash and cash equivalents (39,623) 13,935
Cash and cash equivalents at start of period 121,330 68,789
Effect of exchange rate fluctuations on cash and cash equivalents held 324 219
Cash and cash equivalents, end of period 82,031 82,943
Supplemental disclosures of cash flow information:    
Tax Paid $ (630) $ (326)